| Income Statement for XTL Biopharmaceuticals Ltd. (XTLB) | | | | After Hours: $ 3.06 | 0.00 (0.00%) | Volume: 100 | 4:29 PM EDT Oct 7, 2008 | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 907 | 454 | 3,197 | 3,454 | - | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (2) | 189 | (2,555) | (2,982) | 440 | | Gross Operating Profit | 905 | 643 | 642 | 472 | 440 | | | Selling/General/Admin Expense | (5,582) | (5,576) | (5,457) | (4,134) | (3,105) | | Research & Development | (20,950) | (10,870) | (7,540) | (12,795) | (11,103) | | EBITDA | (25,627) | (15,803) | (12,355) | (16,457) | (13,768) | | Depreciation & Amortization | (108) | (243) | (242) | (319) | (440) | | EBIT | (25,735) | (16,046) | (12,597) | (16,776) | (14,208) | | Interest Income | 668 | 1,058 | 503 | 352 | 352 | | Other Income, Net | (74) | 83 | (60) | - | - | | Total Income Avail For Interest Expense | (25,141) | (14,905) | (13,937) | (16,424) | (14,210) | | Interest Expense | (4) | - | - | - | - | | Pre-Tax Income | (25,145) | (14,905) | (13,937) | (16,424) | (14,210) | | Income Taxes | 206 | (227) | (78) | (49) | (78) | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (24,939) | (15,132) | (14,015) | (16,473) | (14,288) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (24,939) | (15,132) | (14,015) | (16,473) | (14,288) | | | Normalized Income | (24,939) | (15,132) | (12,232) | (16,473) | (13,934) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | (1,783) | - | (354) | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (24,939) | (15,132) | (14,015) | (16,473) | (14,288) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -1.10 | -0.80 | -0.80 | -0.12 | -0.13 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -1.10 | -0.80 | -0.80 | -0.12 | -0.13 | | | Diluted EPS from Continuing Operations | -1.10 | -0.80 | -0.80 | -0.12 | -0.13 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -1.10 | -0.80 | -0.80 | -0.12 | -0.13 | | | |
